HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lorenzo Di Cesare Mannelli Selected Research

3-mercaptopyruvic acid

5/2022Beneficial Effect of H2S-Releasing Molecules in an In Vitro Model of Sarcopenia: Relevance of Glucoraphanin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lorenzo Di Cesare Mannelli Research Topics

Disease

71Pain (Aches)
12/2022 - 09/2010
52Neuralgia (Stump Neuralgia)
06/2022 - 01/2009
31Hypersensitivity (Allergy)
04/2022 - 07/2013
29Neoplasms (Cancer)
04/2022 - 01/2013
13Hyperalgesia
01/2022 - 01/2009
11Colitis
08/2022 - 12/2019
11Inflammation (Inflammations)
08/2022 - 01/2013
11Osteoarthritis
08/2021 - 01/2013
10Rheumatoid Arthritis
10/2021 - 01/2013
9Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 03/2012
8Visceral Pain
02/2022 - 12/2019
8Chronic Pain
02/2022 - 07/2013
7Painful Neuropathy
09/2018 - 06/2014
6Colonic Neoplasms (Colon Cancer)
02/2018 - 01/2014
5Arthritis (Polyarthritis)
02/2022 - 01/2016
5Gliosis
02/2022 - 01/2013
5Hypertension (High Blood Pressure)
06/2021 - 06/2009
4Brain Ischemia (Cerebral Ischemia)
01/2022 - 10/2005
4Abdominal Pain (Pain, Abdominal)
12/2020 - 12/2016
4Wounds and Injuries (Trauma)
01/2019 - 08/2007
3Body Weight (Weight, Body)
08/2022 - 01/2019
3Adenocarcinoma
08/2021 - 01/2018
3Neuroblastoma
11/2019 - 04/2018
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2019 - 01/2016
3Hypoxia (Hypoxemia)
12/2018 - 05/2015
3Neoplasm Metastasis (Metastasis)
09/2018 - 05/2015
3Peripheral Nervous System Diseases (PNS Diseases)
04/2016 - 08/2007
2Sarcopenia
05/2022 - 01/2020
2Epilepsy (Aura)
04/2022 - 09/2018
2Ischemic Stroke
04/2022 - 11/2021
2Demyelinating Diseases (Demyelinating Disease)
01/2022 - 01/2017
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 01/2017
2Nervous System Diseases (Neurological Disorders)
01/2022 - 12/2017

Drug/Important Bio-Agent (IBA)

49Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2022 - 03/2012
20Carbonic Anhydrases (Carbonic Anhydrase)IBA
06/2022 - 04/2015
19Pharmaceutical PreparationsIBA
11/2021 - 08/2007
16Protein Isoforms (Isoforms)IBA
12/2021 - 04/2015
112,4-dinitrofluorobenzene sulfonic acidIBA
08/2022 - 12/2019
11Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2021 - 01/2009
10Opioid Analgesics (Opioids)IBA
02/2022 - 09/2015
10AntioxidantsIBA
06/2021 - 03/2012
8Proteins (Proteins, Gene)FDA Link
04/2022 - 05/2014
7LigandsIBA
01/2022 - 12/2011
7Morphine (MS Contin)FDA LinkGeneric
10/2021 - 01/2015
6Thioctic Acid (Lipoic Acid)IBA
06/2021 - 01/2013
5Paclitaxel (Taxol)FDA LinkGeneric
06/2022 - 11/2015
5CarrageenanIBA
04/2022 - 01/2013
5Streptozocin (Streptozotocin)FDA Link
12/2021 - 04/2011
5Antineoplastic Agents (Antineoplastics)IBA
10/2021 - 07/2013
5Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2021 - 01/2019
5Carbonic Anhydrase InhibitorsIBA
05/2021 - 04/2015
5PlatinumIBA
01/2021 - 11/2014
5SulfonamidesIBA
09/2019 - 04/2015
5Freund's AdjuvantIBA
06/2019 - 01/2013
5isothiocyanic acidIBA
03/2019 - 11/2016
5Acetylcarnitine (Alcar)IBA
04/2018 - 08/2007
4Sulfonic AcidsIBA
08/2022 - 01/2020
4GlucosinolatesIBA
02/2022 - 11/2018
4Potassium Channels (Potassium Channel)IBA
02/2022 - 11/2016
4Glutamic Acid (Glutamate)FDA Link
01/2022 - 10/2005
4N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
01/2022 - 01/2020
42,4-dinitrobenzenesulfonic acidIBA
01/2022 - 01/2020
4Biological ProductsIBA
12/2021 - 03/2018
4Carbonic Anhydrase IXIBA
12/2021 - 11/2017
4BenzenesulfonamidesIBA
01/2021 - 12/2018
4Neuroprotective AgentsIBA
01/2021 - 01/2009
4Analgesics (Analgesic Drugs)IBA
01/2021 - 01/2016
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2020 - 01/2017
4Pregabalin (Lyrica)FDA Link
06/2019 - 04/2011
4Gabapentin (Neurontin)FDA LinkGeneric
04/2018 - 07/2015
4SodiumIBA
12/2017 - 01/2013
32,4-dinitrobenzeneIBA
08/2022 - 01/2020
3Dexamethasone (Maxidex)FDA LinkGeneric
05/2022 - 01/2020
3AcidsIBA
01/2022 - 12/2011
3Cadmium Chloride (Cadmium Dichloride)IBA
01/2022 - 04/2018
3IsothiocyanatesIBA
04/2021 - 07/2017
3Opioid Receptors (Opioid Receptor)IBA
01/2020 - 11/2015
3Ibuprofen (Motrin)FDA LinkGeneric
06/2019 - 07/2015
3NociceptinIBA
03/2018 - 11/2015
3dimiracetamIBA
12/2017 - 06/2014
2glucoraphaninIBA
05/2022 - 11/2018
2CollagenIBA
04/2022 - 08/2013
2LipidsIBA
02/2022 - 12/2019
2glutaminyl- arginyl- phenylalanyl- seryl- arginineIBA
12/2021 - 11/2015
2Opioid Peptides (Opioid Peptide)IBA
12/2021 - 11/2015
2fluorocitrateIBA
11/2021 - 11/2014
2Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
10/2021 - 01/2020
2Monoclonal AntibodiesIBA
10/2021 - 01/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 01/2018
2Interleukin-6 (Interleukin 6)IBA
10/2021 - 01/2020
2Interleukin-10 (Interleukin 10)IBA
10/2021 - 01/2021

Therapy/Procedure

25Therapeutics
02/2022 - 07/2013
20Drug Therapy (Chemotherapy)
01/2022 - 07/2013
6Ligation
01/2021 - 08/2007
4Oral Administration
12/2020 - 10/2017
4Analgesia
01/2020 - 05/2011
4Intra-Articular Injections
01/2018 - 07/2015
4Aftercare (After-Treatment)
12/2017 - 05/2014
2Spinal Injections
10/2021 - 01/2018
2Drug Tapering
10/2021 - 04/2016